Onk Therapeutics Limited
Records under this name other than the patents Onk Therapeutics Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.
Showing 1 to 2 of 2 · Back to Onk Therapeutics Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,841,418 | Antibodies That Specifically Bind to TIM3 Lapsed on the fee record Ended Sep 23, 2026 · High confidence | Lapsed on the fee record | Ended Sep 23, 2026 | High confidence |
| US 10,034,925 | Modified Natural Killer Cells and Natural Killer Cell Lines Having Increased Cytotoxicity Lapsed on the fee record Ended Jul 31, 2026 · High confidence | Lapsed on the fee record | Ended Jul 31, 2026 | High confidence |